Avacta Group.
65 announcements.
65 announcements.
| Time | Date | Ticker | Company | Announcement |
|---|---|---|---|---|
| 07:00 | 16-01-2025 | AVCT | Avacta Group | Avacta Announces Data from AVA6000 Phase 1 trial |
| 07:00 | 13-01-2025 | AVCT | Avacta Group | Avacta Appoints Chief Financial Officer |
| 07:00 | 12-12-2024 | AVCT | Avacta Group | Completion of Dose Escalation and RDE Arms |
| 07:00 | 30-10-2024 | AVCT | Avacta Group | R&D Spotlight focusing on pipeline advances |
| 07:00 | 28-10-2024 | AVCT | Avacta Group | Block Listing Six Monthly Return |
| 07:00 | 24-10-2024 | AVCT | Avacta Group | Avacta Reports Pipeline Avances at EORTC |
| 16:00 | 21-10-2024 | AVCT | Avacta Group | Issue of Equity and Total Voting Rights |
| 07:00 | 21-10-2024 | AVCT | Avacta Group | Avacta and Tempus Enter Strategic Collaboration |
| 07:00 | 17-10-2024 | AVCT | Avacta Group | Avacta Expands its Pipeline |
| 07:00 | 15-10-2024 | AVCT | Avacta Group | Avacta appoints Chief Scientific Officer |
| 07:00 | 10-10-2024 | AVCT | Avacta Group | Avacta Unveils Pipeline Expansion at EORTC 2024 |
| 07:00 | 30-09-2024 | AVCT | Avacta Group | Interim Results |
| 07:00 | 16-09-2024 | AVCT | Avacta Group | Avacta Reported Updated Phase 1 Data of AVA6000 |
| 07:00 | 12-09-2024 | AVCT | Avacta Group | Notice of Results |
| 07:00 | 09-09-2024 | AVCT | Avacta Group | Avacta to present clinical data at ESMO Congress |
| 15:53 | 02-09-2024 | AVCT | Avacta Group | Director/PDMR Shareholdings and TVR |
| 07:00 | 18-07-2024 | AVCT | Avacta Group | Convertible Bond Payment |
| 14:46 | 26-06-2024 | AVCT | Avacta Group | Result of AGM |
| 07:00 | 26-06-2024 | AVCT | Avacta Group | AGM Business Update |
| 07:00 | 20-06-2024 | AVCT | Avacta Group | Shaun Chilton appointed Non-Executive Chairman |
| 07:00 | 11-06-2024 | AVCT | Avacta Group | Appointment of Nominated Adviser and Sole Broker |
| 07:00 | 31-05-2024 | AVCT | Avacta Group | Posting of Annual Report and Notice of AGM |
| 07:00 | 23-05-2024 | AVCT | Avacta Group | Successful Completion of First Cohort |
| 07:00 | 30-04-2024 | AVCT | Avacta Group | Board Change |
| 07:01 | 30-04-2024 | AVCT | Avacta Group | Full Year Results |
| 09:51 | 26-04-2024 | AVCT | Avacta Group | Block listing Interim Return REPLACEMENT |
| 07:00 | 26-04-2024 | AVCT | Avacta Group | Block Listing Six Monthly Return |
| 09:43 | 23-04-2024 | AVCT | Avacta Group | Block Listing Application to AIM |
| 07:00 | 23-04-2024 | AVCT | Avacta Group | Notice of Results |
| 12:14 | 22-04-2024 | AVCT | Avacta Group | Issue of Equity and Total Voting Rights |
| 17:00 | 09-04-2024 | AVCT | Avacta Group | Avacta Reports Data at the AACR Annual Meeting |
| 07:00 | 08-04-2024 | AVCT | Avacta Group | AVA6000 Abstract Release by AACR |
| 07:00 | 21-03-2024 | AVCT | Avacta Group | Update on AVA6000 Phase 1a Clinical Trial Progress |
| 13:26 | 18-03-2024 | AVCT | Avacta Group | Result of General Meeting |
| 07:00 | 06-03-2024 | AVCT | Avacta Group | Avacta Announces AVA6000 Poster at AACR |
| 07:00 | 05-03-2024 | AVCT | Avacta Group | Result of REX Retail Offer |
| 07:00 | 29-02-2024 | AVCT | Avacta Group | Result of Placing |
| 16:42 | 28-02-2024 | AVCT | Avacta Group | Proposed REX Retail Offer |
| 16:41 | 28-02-2024 | AVCT | Avacta Group | Proposed Fundraise to progress Therapeutics |
| 07:00 | 16-02-2024 | AVCT | Avacta Group | Share Incentive Plan/Issue of Equity |
| 10:51 | 22-01-2024 | AVCT | Avacta Group | Issue of Equity and Total Voting Rights |
| 07:00 | 19-01-2024 | AVCT | Avacta Group | Appointment of Christina Coughlin |
| 07:00 | 19-12-2023 | AVCT | Avacta Group | Appointment of Chief Business Officer |
| 07:00 | 13-12-2023 | AVCT | Avacta Group | ALS-6000-101 Phase 1a Study Data |
| 07:00 | 04-12-2023 | AVCT | Avacta Group | Shareholder update to review AVA6000 Phase 1a data |
| 07:00 | 27-10-2023 | AVCT | Avacta Group | Block Listing Six Monthly Return |
| 13:30 | 23-10-2023 | AVCT | Avacta Group | Issue of Equity and Total Voting Rights |
| 13:00 | 18-10-2023 | AVCT | Avacta Group | Block Listing Application to AIM |
| 07:00 | 05-10-2023 | AVCT | Avacta Group | Avacta to present at AACR-NCI-EORTC conference |
| 07:00 | 28-09-2023 | AVCT | Avacta Group | Interim Results for the Period Ending 30 June 2023 |
| 14:00 | 20-09-2023 | AVCT | Avacta Group | Issue of Equity and Total Voting Rights |
| 07:01 | 20-09-2023 | AVCT | Avacta Group | Peel Hunt Appointed as Joint Broker |
| 07:00 | 20-09-2023 | AVCT | Avacta Group | Appointment Dr.Christina Coughlin as a consultant |
| 07:00 | 19-09-2023 | AVCT | Avacta Group | Successful Completion of Sixth Dose Escalation |
| 07:00 | 06-09-2023 | AVCT | Avacta Group | Notice of Results |
| 15:00 | 21-07-2023 | AVCT | Avacta Group | Issue of Equity and Total Voting Rights |
| 11:00 | 28-06-2023 | AVCT | Avacta Group | Result of Annual General Meeting |
| 07:00 | 28-06-2023 | AVCT | Avacta Group | Annual General Meeting and Shareholder Event |
| 07:00 | 21-06-2023 | AVCT | Avacta Group | Completion of Fifth Dose Escalation in AVA6000 |
| 07:01 | 19-06-2023 | AVCT | Avacta Group | Director Appointment |
| 07:00 | 19-06-2023 | AVCT | Avacta Group | Statement regarding market speculation |
| 07:00 | 08-06-2023 | AVCT | Avacta Group | AGM and Shareholder Event Detailed Agenda |
| 07:00 | 05-06-2023 | AVCT | Avacta Group | Second Milestone in AffyXell Joint Venture |
| 07:00 | 02-06-2023 | AVCT | Avacta Group | Posting of Annual Report and Notice of AGM |
| 07:00 | 01-06-2023 | AVCT | Avacta Group | Avacta acquires Coris Bioconcept |